LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Drug-Radiation combo tested for tough pancreatic tumors
Disease control Recruiting nowThis early-stage study is testing whether a new drug called XER-001, delivered directly to the small intestine, can be safely combined with precise radiation therapy for pancreatic cancer that hasn't spread. Researchers want to find the best dose and see if this combination helps…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Xerient Pharma • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New hope for tough pancreatic cancers: trial tests Immune-Boosting drug combo
Disease control Recruiting nowThis study is testing whether adding two new drugs (zimberelimab and quemliclustat) to standard chemotherapy can help people with pancreatic cancer that is difficult or impossible to remove with surgery. The new drugs aim to boost the immune system's ability to fight the cancer. …
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Genetic clues to target pancreatic cancer faster
Disease control Recruiting nowThis study aims to see if quickly analyzing the genetic makeup of a pancreatic tumor can help doctors choose the most effective treatment. It will enroll 200 adults with pancreatic cancer that has not spread to distant organs. Participants will receive standard chemotherapy and p…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Breakthrough radiation technique offers hope for tough pancreatic tumors
Disease control Recruiting nowThis study is testing a new radiation therapy approach called PULSAR combined with standard chemotherapy for people with advanced pancreatic cancer. The PULSAR method delivers radiation in spaced-out 'pulses' over several weeks, which may reduce side effects while better targetin…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New scan could reveal if pancreatic cancer treatment is working sooner
Diagnosis Recruiting nowThis study is testing a new, experimental type of MRI scan that looks at how a pancreatic tumor uses energy. The goal is to see if this scan can tell doctors earlier than current scans whether a patient's standard cancer treatment is working. About 70 adults with advanced pancrea…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Mar 06, 2026 15:37 UTC
-
Scientists probe six drugs in race to outsmart pancreatic cancer
Knowledge-focused Recruiting nowThis early study aims to understand how six different investigational drugs affect the biology of pancreatic cancer tumors. It will enroll about 90 adults with various stages of pancreatic cancer. Participants take one of the drugs for about 10 days before a scheduled biopsy or s…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists probe new Drug's effect on deadly pancreatic tumors
Knowledge-focused Recruiting nowThis early research study aims to understand how an experimental drug called OMO-103 affects pancreatic cancer cells in patients. Twelve adults with advanced pancreatic cancer will receive two infusions of the drug and undergo tumor biopsies to see if it changes the tumor's biolo…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC